Drug Type Interferons |
Synonyms Algeron, CEPEG-IFN, Cepeginterferon Alfa 2 B + [2] |
Target |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date RU (01 Dec 2013), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hepatitis C | RU | 01 Dec 2013 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C, Chronic | Phase 3 | RU | 06 Jun 2013 | |
HIV Infections | Phase 3 | RU | 06 Jun 2013 |
Phase 2/3 | 150 | nggmpizluh(bnjjartgmc) = gijupgakdq omrnburifx (uwxpkskgpq, zjnjzwnhzd - jepesxapeb) View more | - | 18 Aug 2015 | |||
nggmpizluh(bnjjartgmc) = zndqajrror omrnburifx (uwxpkskgpq, ajmqfhxjhb - lanhfnckoa) View more | |||||||
Phase 3 | 140 | (Algeron) | bgybwkhqmv(yfnbryykyp) = mrnnaqmgwe sfxdofdloq (bhgqzqiwcw, odufesudzk - gsifslatzu) View more | - | 21 Jul 2015 | ||
(PegIntron) | bgybwkhqmv(yfnbryykyp) = ftsefghglv sfxdofdloq (bhgqzqiwcw, krjaegnaoc - hjeqbklgat) View more |